Liang Kai, Dai Jian-Ye
School of Life Science, Peking University, Beijing, China.
School of Pharmacy, Lanzhou University, Lanzhou, China.
Front Pharmacol. 2022 Dec 16;13:1067652. doi: 10.3389/fphar.2022.1067652. eCollection 2022.
Lipids are a class of complex hydrophobic molecules derived from fatty acids that not only form the structural basis of biological membranes but also regulate metabolism and maintain energy balance. The role of lipids in obesity and other metabolic diseases has recently received much attention, making lipid metabolism one of the attractive research areas. Several metabolic diseases are linked to lipid metabolism, including diabetes, obesity, and atherosclerosis. Additionally, lipid metabolism contributes to the rapid growth of cancer cells as abnormal lipid synthesis or uptake enhances the growth of cancer cells. This review introduces the potential drug targets in lipid metabolism and summarizes the important potential drug targets with recent research progress on the corresponding small molecule inhibitor drugs. The significance of this review is to provide a reference for the clinical treatment of metabolic diseases related to lipid metabolism and the treatment of tumors, hoping to deepen the understanding of lipid metabolism and health.
脂质是一类源自脂肪酸的复杂疏水分子,它们不仅构成生物膜的结构基础,还调节新陈代谢并维持能量平衡。脂质在肥胖症和其他代谢性疾病中的作用最近备受关注,使得脂质代谢成为有吸引力的研究领域之一。几种代谢性疾病与脂质代谢有关,包括糖尿病、肥胖症和动脉粥样硬化。此外,脂质代谢有助于癌细胞的快速生长,因为异常的脂质合成或摄取会促进癌细胞的生长。本综述介绍了脂质代谢中的潜在药物靶点,并总结了具有相应小分子抑制剂药物近期研究进展的重要潜在药物靶点。本综述的意义在于为与脂质代谢相关的代谢性疾病的临床治疗以及肿瘤治疗提供参考,希望加深对脂质代谢与健康的理解。